Month: March 2020

EEZY OYJ  —  YHTIÖTIEDOTE  —  25.3.2020 KLO 14.15Eezy Oyj:n tilinpäätös, hallinnointiselvitys sekä palkkioselvitys vuodelta 2019 on julkaistuEezy Oyj on julkaissut tilinpäätöksen ja toimintakertomuksen, selvityksen hallinnointi- ja ohjausjärjestelmästä sekä palkka- ja palkkioselvityksen vuodelta 2019.Yhtiö on muuttanut näkymiään ja osinkoesitystä 5.3.2020 julkistetun tilinpäätöstiedotteen jälkeen. Yhtiö tiedotti 20.3.2020, että yhtiö luopuu tulosennusteesta vuodelle 2020. Samalla tiedotettiin, että hallitus muuttaa osinkoehdotustaan siten, että yhtiökokouksessa ei päätetä osingonmaksusta keväällä, vaan yhtiökokous valtuuttaa hallituksen päättämään myöhemmin enintään 0,20 eur/osake osingon jakamisesta vuoden 2020 loppuun mennessä.Eezy Oyj on myös julkaissut yhtiön liiketoimintaa esittelevän liiketoimintakatsauksen, joka on...

STAMFORD, Conn., March 25, 2020 (GLOBE NEWSWIRE) — Experts from Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, will discuss the impact of India’s COVID-19 lockdown on service continuity and data security during an ISG Smartalks™ webinar tomorrow.The live, hour-long session, “How to Maintain Business Continuity as Providers Shift to a Remote Workforce,” at 1 p.m., U.S. Eastern Time, March 26, will review the implications of the just-announced, 21-day nationwide lockdown in India and the immediate steps enterprise customers should take to adapt to the new reality of their service providers working remotely.Stanton Jones, director and principal analyst, ISG Research, will moderate the discussion with Brian Thompson, partner, and Thomas Barnekow, service line director, ISG Sourcing...

Nasdaq OMX Copenhagen        Skjern, 25. marts 2020Nikolaj Plads 61007 København KVedhæftet fil06_Suspendering af forventningerne til 2020

BARRIE, Ontario, March 25, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it has completed its first shipment of bottled cannabis topicals under a contract manufacturing agreement. The Company also announced it is accelerating its research and development program to expand the Company’s presence in the growing Canadian, and future international, medical and adult-use topicals markets.First Topical ShipmentsLeveraging the Company’s 25,000 sq. ft. licensed space, the Company completed its first shipment of topicals from its GMP-certified Barrie facility this week including the filling and packaging on behalf of its customer....

Westport, CT, March 25, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform, today announced that its majority-owned subsidiary NeuroClear Technologies, Inc. acquired the rights to develop a novel pharmaceutical to treat Coronavirus Disease 2019 (COVID-19).In a preliminary internal review, the orally administered, broad-spectrum anti-viral agent Vicromax(tm) demonstrated strong activity against COVID-19 in cell cultures in laboratory testing. In this analysis, Vicromax(tm) was added to a tissue culture assay for SARS-CO-2 coronavirus (the causative agent for COVID-19) and an anti-viral effect was observed, which led to a reduction of over 90% of infectious viruses. The Company intends to pursue...

Styrelsen för NGS Group AB (publ) har idag, till följd av utbrottet av coronaviruset Covid-19, beslutat skjuta upp årsstämman. Skälet är att NGS vill undvika risken för smittspridning genom att samla aktieägarna.NGS återkommer med ny kallelse till årsstämma senast fyra veckor före det nya datumet. Årsstämman kommer att hållas den 2 juni 2020 klockan 16.00.Den rådande situationen med coronaviruset kan innebära både ökade behov av våra tjänster exempelvis inom vården, men även minskad efterfrågan på våra tjänster inom specialist- och chefsrekrytering beroende på hur marknadssituationen för våra kunder utvecklas. När detta skrivs är det ännu för tidigt att uttala sig om vad effekten av Covid-19 blir på de marknader NGS verkar. NGS arbetar med fullt fokus på de möjligheter som finns och med uppdraget att lösa kundernas behov. Detta sker parallellt...

—  Strong Sales Growth Continues to Outperform the RV Industry  — —  Quarterly Revenues Increased 45%, including Robust Organic Growth of 13%  ——  Reported Quarterly Diluted EPS of $0.51, Adjusted EPS of $0.67 Up 9.8% Over Prior Year  ——  YTD Operating Cash Flow Up 129% Over Prior Year  — —  First Full Quarter of Contribution From Newmar with Integration Progressing as Planned  —FOREST CITY, Iowa, March 25, 2020 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE:WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s second quarter Fiscal 2020.Second Quarter Fiscal 2020 ResultsRevenues for the Fiscal 2020 second quarter ended February 29, 2020, increased 44.9% to $626.8 million compared to $432.7 million for the...

Press ReleaseNokia completes acquisition of Elenion Technologies25 March 2020Espoo, Finland – Nokia today announced the successful completion of its acquisition of Elenion Technologies, a U.S.-based company focusing on silicon photonics technology. The planned acquisition was originally announced February 19, 2020.Elenion’s technology expertise and unique design platform and services enable Nokia to expand its market footprint by addressing the critical and rapidly evolving optical connectivity requirements of 5G, cloud and enterprise networking. Ownership of these key assets brings time-to-market and cost advantages to Nokia’s broad portfolio of networking solutions by applying the massive scale and economies of silicon design and manufacturing to the optical supply chain.About NokiaWe create the technology to connect the world. Only...

PRESS RELEASEAudited Full Year Results for the year ended 31 December 2019Revenue £68.3m (up 26.1%)Adjusted EBITDA £12.5m (up from £2.3m in 2018)Order book of future contracted revenue £124.1 million (up 13.6%)New £30m credit facilityGuildford, UK – 25 March 2020: Ergomed plc (LSE: ERGO) (‘Ergomed’ or the ‘Company’), a company focused on providing specialised services to the pharmaceutical industry, today announces its audited Full Year Results for the year ended 31 December 2019.Selected Financial HighlightsDr Miroslav Reljanović, Executive Chairman of Ergomed, said: “2019 has been a transformational year for Ergomed, delivering strong financial results and executing our focused strategy to become a leading global provider of specialist services to the pharmaceutical industry. We performed strongly across the...

– On track to report topline data for KALM-2 Phase 3 global trial of  KORSUVA™ Injection in second quarter –                   – On track to complete interim statistical analysis for ongoing Phase 2 trial of Oral KORSUVA in atopic dermatitis in second quarter –– Timeline to submit KORSUVA Injection New Drug Application to FDA in second half of 2020 remains unchanged –STAMFORD, Conn., March 25, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced that it is on track to report topline data in the second quarter of 2020 from its ongoing pivotal KALM-2 Phase 3 global trial of KORSUVA™ Injection...